000			01921 a2200541 4500
005			20250517232046.0
264		0	_c20190107
008			201901s 0 0 eng d
022			_a1471-2407
024	7		_a10.1186/s12885-018-4641-x _2doi
040			_aNLM _beng _cNLM
100	1		_aRedmond, H Paul
245	0	0	_aRandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial. _h[electronic resource]
260			_bBMC cancer _cAug 2018
300			_a794 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBiomarkers _xblood
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aColectomy _xadverse effects
650	0	4	_aColonic Neoplasms _xpathology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInflammation _xblood
650	0	4	_aInflammation Mediators _xblood
650	0	4	_aInterleukin-6 _xblood
650	0	4	_aIreland
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xprevention & control
650	0	4	_aRisk Factors
650	0	4	_aSurgical Wound Infection _xprevention & control
650	0	4	_aTaurine _xadministration & dosage
650	0	4	_aThiadiazines _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aNeary, Peter M
700	1		_aJinih, Marcel
700	1		_aO'Connell, Emer
700	1		_aFoley, Niamh
700	1		_aPfirrmann, Rolf W
700	1		_aWang, Jiang H
700	1		_aO'Leary, D Peter
773	0		_tBMC cancer _gvol. 18 _gno. 1 _gp. 794
856	4	0	_uhttps://doi.org/10.1186/s12885-018-4641-x _zAvailable from publisher's website
999			_c28704652 _d28704652